Presentation of new preclinical data on 4P004, our disease-modifying treatment candidate for osteoarthritis, highlighting its protective effects in osteoarthritis models

A poster entitled “Protective Effects of Intra-Articular Formulated Liraglutide in Osteoarthritis: Preclinical Studies” (#1973), presenting data on 4P004, will be presented at the ACR/ARP Annual Meeting in Atlanta, Georgia, November 8–13, 2019. The presentation will be delivered by Prof. Francis Berenbaum, Professor of Rheumatology at Sorbonne University, Paris, France. For further information, please click on the following link here .

The release as fetched from its publisher. 4movingbiotech.com ↗